Gene: CALM2

805
CAMII|LQT15|PHKD|PHKD2|caM
calmodulin 2
protein-coding
2p21
Ensembl:ENSG00000143933 MIM:114182 Vega:OTTHUMG00000128850 UniprotKB:P0DP24
NG_042065.1
PubMed
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
9.359e-1 (AD)  8.787e-1 (ND)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
AP3S10.967
MORF4L10.966
BEX40.964
PEBP10.964
NGRN0.957
BRK10.956
EIF4A20.955
MRFAP1L10.955
PPIA0.955
EMC40.954

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.869
OR4F29-0.857
KCNJ15-0.267
FOLR3-0.258
RUNX3-0.25
TFPI2-0.246
CXCR2-0.24
SIX1-0.237
MTRNR2L6-0.236
MAGEA12-0.233

Drugs/Compounds

ID Drug Name Drug Type CAS Num Status Role
DB11093Calcium CitrateSmall Molecule813-94-5ApprovedTarget
DB11348Calcium PhosphateSmall Molecule10103-46-5ApprovedTarget
ID Drug Name Action PubMed
C0235142,6-dinitrotoluene"2,6-dinitrotoluene affects the expression of CALM2 mRNA"21346803
C5116212-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in decreased expression of CALM2 mRNA]28655636
C5116212-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in decreased expression of CALM2 mRNA]28655636
C0163923,3'-diindolylmethane"3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of CALM2 mRNA]"11179685
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of CALM2 gene27153756
D000643Ammonium ChlorideAmmonium Chloride affects the expression of CALM2 mRNA16483693
D000661AmphetamineAmphetamine affects the expression of CALM2 mRNA10854758
D018501Antirheumatic AgentsAntirheumatic Agents results in decreased expression of CALM2 mRNA25339124
C015001arsenitearsenite results in increased methylation of CALM2 promoter23974009
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of CALM2 mRNA22228805
D004958Estradiol"3,3'-diindolylmethane promotes the reaction [Estradiol results in decreased expression of CALM2 mRNA]"11179685
D004958EstradiolEstradiol results in decreased expression of CALM2 mRNA11179685
D004958EstradiolTetrachlorodibenzodioxin promotes the reaction [Estradiol results in decreased expression of CALM2 mRNA]11179685
D004958Estradiol[bisphenol A co-treated with Estradiol] results in increased expression of CALM2 mRNA26496021
C006780bisphenol A[bisphenol A co-treated with Estradiol] results in increased expression of CALM2 mRNA26496021
C006780bisphenol Abisphenol A results in increased methylation of CALM2 gene28505145
C005961bis(tri-n-butyltin)oxidebis(tri-n-butyltin)oxide results in decreased expression of CALM2 mRNA18958704
C515564bromovaninbromovanin results in increased expression of CALM2 protein21419150
D002065BuspironeBuspirone results in decreased expression of CALM2 mRNA24136188
D002101Cacodylic AcidCacodylic Acid results in increased expression of CALM2 mRNA16122865
D019256Cadmium ChlorideCadmium Chloride results in decreased expression of CALM2 mRNA25035189
D019256Cadmium ChlorideSelenium inhibits the reaction [Cadmium Chloride results in decreased expression of CALM2 mRNA]25035189
D002186CannabinoidsCannabinoids results in decreased expression of CALM2 mRNA17205118
C026690cerous chloridecerous chloride results in increased expression of CALM2 mRNA23573234
D020111Chlorodiphenyl (54% Chlorine)Chlorodiphenyl (54% Chlorine) results in decreased expression of CALM2 mRNA23650126
C100187chloropicrinchloropicrin results in increased expression of CALM2 mRNA26352163
D002995Clofibric Acid[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CALM2 mRNA17602206
D003024ClozapineClozapine results in increased expression of CALM2 mRNA19289156
D003042CocaineCocaine results in decreased expression of CALM2 mRNA17205118
D003300CopperCopper results in decreased expression of CALM2 mRNA25646894
D019327Copper SulfateCopper Sulfate results in decreased expression of CALM2 mRNA19549813
D003471CuprizoneCuprizone results in decreased expression of CALM2 mRNA26577399
C057862cyanoginosin LRcyanoginosin LR results in increased expression of CALM2 mRNA17654400
C009160cyclonitecyclonite affects the expression of CALM2 mRNA19417177
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in decreased expression of CALM2 mRNA27392435
D002945CisplatinCisplatin results in decreased expression of CALM2 mRNA27392435
C000944dicrotophosdicrotophos results in decreased expression of CALM2 mRNA28302478
D004026DieldrinDieldrin affects the expression of CALM2 mRNA22546817
D004041Dietary FatsDietary Fats results in increased expression of CALM2 mRNA18042831
D004052Diethylnitrosamine[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CALM2 mRNA17602206
D004237DiuronDiuron results in increased expression of CALM2 mRNA21551480
D000431EthanolEthanol results in decreased expression of CALM2 mRNA20655511
D004997Ethinyl EstradiolEthinyl Estradiol results in increased expression of CALM2 protein20381887
C056933fumonisin B1fumonisin B1 results in increased expression of CALM2 mRNA16221962
D005839GentamicinsGentamicins results in increased expression of CALM2 mRNA22061828
D005947GlucoseCALM2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]21124846
D005947Glucose[INS protein co-treated with Glucose] results in decreased expression of CALM2 mRNA22634610
D006220HaloperidolHaloperidol results in increased expression of CALM2 mRNA19289156
D006861Hydrogen PeroxideHydrogen Peroxide affects the expression of CALM2 mRNA20044591
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CALM2 mRNA25613284
C544151jinfukang[Cisplatin co-treated with jinfukang] results in decreased expression of CALM2 mRNA27392435
C544151jinfukangjinfukang results in decreased expression of CALM2 mRNA27392435
C410337K 7174K 7174 results in decreased expression of CALM2 mRNA24086573
D008344Maneb[Paraquat co-treated with Maneb] results in increased expression of CALM2 mRNA18386188
D008727MethotrexateMethotrexate results in increased expression of CALM2 mRNA21678067
D015735MifepristoneMifepristone inhibits the reaction [Progesterone results in decreased expression of CALM2 mRNA]27264040
C568376MT19c compoundMT19c compound results in increased expression of CALM2 mRNA21781307
C051752nefazodonenefazodone results in decreased expression of CALM2 mRNA24136188
C022838nickel chloridenickel chloride affects the expression of CALM2 mRNA22546817
C012655nimesulidenimesulide results in decreased expression of CALM2 mRNA24136188
D005996NitroglycerinNitroglycerin results in increased expression of CALM2 mRNA12102619
D019319Okadaic AcidOkadaic Acid results in decreased expression of CALM2 mRNA23561263
D010100OxygenCALM2 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency]21124846
D000073878Palm OilPalm Oil results in increased expression of CALM2 mRNA18042831
D010269Paraquat[Paraquat co-treated with Maneb] results in increased expression of CALM2 mRNA18386188
D052638Particulate Matter2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in decreased expression of CALM2 mRNA]28655636
D052638Particulate MatterParticulate Matter results in decreased expression of CALM2 mRNA28412507|2865563
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in decreased expression of CALM2 mRNA19756518
C076994perfluorooctane sulfonic acidperfluorooctane sulfonic acid results in increased expression of CALM2 mRNA19756518
D010622PhencyclidinePhencyclidine results in decreased expression of CALM2 mRNA17205118
D010634PhenobarbitalPhenobarbital affects the expression of CALM2 mRNA19159669
D010672PhenytoinPhenytoin results in decreased expression of CALM2 mRNA14741686
D010936Plant ExtractsPlant Extracts results in increased expression of CALM2 mRNA23557933
D011374ProgesteroneMifepristone inhibits the reaction [Progesterone results in decreased expression of CALM2 mRNA]27264040
D011374ProgesteroneProgesterone results in decreased expression of CALM2 mRNA27264040
D018967RisperidoneRisperidone results in increased expression of CALM2 mRNA19289156
D012643SeleniumSelenium inhibits the reaction [Cadmium Chloride results in decreased expression of CALM2 mRNA]25035189
D012969Sodium FluorideSodium Fluoride results in increased expression of CALM2 mRNA21340527
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin promotes the reaction [Estradiol results in decreased expression of CALM2 mRNA]11179685
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CALM2 mRNA21570461
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of CALM2 mRNA25613284
D014118Toxins, Biological"Toxins, Biological affects the expression of CALM2 mRNA"19682533
D014241TrichloroethyleneTrichloroethylene results in increased methylation of CALM2 gene27618143
C012589trichostatin Atrichostatin A results in increased expression of CALM2 mRNA15901671
D014415TunicamycinTunicamycin results in decreased expression of CALM2 mRNA22378314
D014501UraniumUranium affects the expression of CALM2 mRNA15672453
D017974Uranium CompoundsUranium Compounds results in decreased expression of CALM2 mRNA19654044
C005460uranyl acetateuranyl acetate affects the expression of CALM2 mRNA15672453
D014635Valproic AcidValproic Acid results in decreased methylation of CALM2 gene29154799
D014635Valproic AcidValproic Acid results in increased expression of CALM2 mRNA19101580
D014635Valproic AcidValproic Acid results in increased expression of CALM2 mRNA15901671
D001335Vehicle Emissions2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in decreased expression of CALM2 mRNA]28655636
D001335Vehicle EmissionsVehicle Emissions results in decreased expression of CALM2 mRNA28655636
D014750VincristineVincristine results in decreased expression of CALM2 mRNA23649840

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005509calcium ion binding-IDA7607248  8631777  11807546  23040497  26164367  26969752  
27516456  
GO:0005515protein binding-IPI3111527  10692436  15140941  16760425  19855925  21299499  
GO:0008179adenylate cyclase binding-IPI11807546  
GO:0019855calcium channel inhibitor activity-IDA26969752  
GO:0019901protein kinase binding-IPI20668654  
GO:0019904protein domain specific binding-IPI11984006  
GO:0031432titin binding-IPI7607248  
GO:0031997N-terminal myristoylation domain binding-IPI15632291  
GO:0043539protein serine/threonine kinase activator activity-TAS20668654  
GO:0044325ion channel binding-IPI21167176  23040497  
GO:0072542protein phosphatase activator activity-IDA8631777  
GO:0097718disordered domain specific binding-IPI19855925  
GO ID GO Term Qualifier Evidence PubMed
GO:0002027regulation of heart rate-IMP23040497  
GO:0005513detection of calcium ion-IMP23040497  
GO:0007186G-protein coupled receptor signaling pathway-TAS10899953  
GO:0010800positive regulation of peptidyl-threonine phosphorylation-TAS20668654  
GO:0010801negative regulation of peptidyl-threonine phosphorylation-TAS20668654  
GO:0010880regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum-IDA20226167  
GO:0010881regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion-IC-  
GO:0021762substantia nigra development-HEP22926577  
GO:0031954positive regulation of protein autophosphorylation-TAS20668654  
GO:0032465regulation of cytokinesis-IMP16760425  
GO:0032516positive regulation of phosphoprotein phosphatase activity-IDA8631777  
GO:0035307positive regulation of protein dephosphorylation-IDA8631777  
GO:0051343positive regulation of cyclic-nucleotide phosphodiesterase activity-IDA8631777  
GO:0051592response to calcium ion-IDA7607248  
GO:0055117regulation of cardiac muscle contraction-IMP23040497  
GO:0060315negative regulation of ryanodine-sensitive calcium-release channel activity-IDA26164367  
GO:0060316positive regulation of ryanodine-sensitive calcium-release channel activity-IDA20226167  
GO:0071902positive regulation of protein serine/threonine kinase activity-TAS20668654  
GO:1901844regulation of cell communication by electrical coupling involved in cardiac conduction-IC-  
GO ID GO Term Qualifier Evidence PubMed
GO:0000922spindle pole-IDA16760425  
GO:0005634nucleus-HDA21630459  
GO:0005737cytoplasm-IDA27165696  
GO:0005737cytoplasm-TAS10899953  
GO:0005813centrosome-IDA16760425  
GO:0005876spindle microtubule-IDA16760425  
GO:0005886plasma membrane-TAS10899953  
GO:0030017sarcomere-IDA20226167  
GO:0031982vesicle-HDA19190083  
GO:0032991protein-containing complex-IDA19855925  
GO:0034704calcium channel complex-IDA23040497  
GO:1902494catalytic complex-IDA11807546  
KEGG ID KEGG Term
hsa04020Calcium signaling pathway
hsa04070Phosphatidylinositol signaling system
hsa04114Oocyte meiosis
hsa04270Vascular smooth muscle contraction
hsa04720Long-term potentiation
hsa04722Neurotrophin signaling pathway
hsa04740Olfactory transduction
hsa04744Phototransduction
hsa04910Insulin signaling pathway
hsa04912GnRH signaling pathway
hsa04916Melanogenesis
hsa04970Salivary secretion
hsa04971Gastric acid secretion
hsa05010Alzheimer's disease
hsa05214Glioma
Reactome ID Reactome Term Evidence
R-HSA-109582HemostasisTAS
R-HSA-111885Opioid SignallingTAS
R-HSA-111885Opioid SignallingIEA
R-HSA-111931PKA-mediated phosphorylation of CREBTAS
R-HSA-111932CaMK IV-mediated phosphorylation of CREBTAS
R-HSA-111932CaMK IV-mediated phosphorylation of CREBIEA
R-HSA-111933Calmodulin induced eventsTAS
R-HSA-111933Calmodulin induced eventsIEA
R-HSA-111957Cam-PDE 1 activationTAS
R-HSA-111996Ca-dependent eventsTAS
R-HSA-111996Ca-dependent eventsIEA
R-HSA-111997CaM pathwayTAS
R-HSA-111997CaM pathwayIEA
R-HSA-112040G-protein mediated eventsTAS
R-HSA-112040G-protein mediated eventsIEA
R-HSA-112043PLC beta mediated eventsTAS
R-HSA-112043PLC beta mediated eventsIEA
R-HSA-112314Neurotransmitter receptors and postsynaptic signal transmissionTAS
R-HSA-112314Neurotransmitter receptors and postsynaptic signal transmissionIEA
R-HSA-112315Transmission across Chemical SynapsesTAS
R-HSA-112315Transmission across Chemical SynapsesIEA
R-HSA-112316Neuronal SystemTAS
R-HSA-112316Neuronal SystemIEA
R-HSA-114608Platelet degranulation TAS
R-HSA-1168372Downstream signaling events of B Cell Receptor (BCR)TAS
R-HSA-1168372Downstream signaling events of B Cell Receptor (BCR)IEA
R-HSA-1280218Adaptive Immune SystemTAS
R-HSA-1280218Adaptive Immune SystemIEA
R-HSA-1430728MetabolismTAS
R-HSA-1430728MetabolismIEA
R-HSA-1445148Translocation of GLUT4 to the plasma membraneIEA
R-HSA-1474151Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulationTAS
R-HSA-1483249Inositol phosphate metabolismTAS
R-HSA-1489509DAG and IP3 signalingTAS
R-HSA-1489509DAG and IP3 signalingIEA
R-HSA-1592230Mitochondrial biogenesisIEA
R-HSA-162582Signal TransductionTAS
R-HSA-162582Signal TransductionIEA
R-HSA-163615PKA activationTAS
R-HSA-1643685DiseaseTAS
R-HSA-168249Innate Immune SystemTAS
R-HSA-168249Innate Immune SystemIEA
R-HSA-168256Immune SystemTAS
R-HSA-168256Immune SystemIEA
R-HSA-180024DARPP-32 eventsIEA
R-HSA-1852241Organelle biogenesis and maintenanceIEA
R-HSA-1855204Synthesis of IP3 and IP4 in the cytosolTAS
R-HSA-194138Signaling by VEGFIEA
R-HSA-194138Signaling by VEGFTAS
R-HSA-194315Signaling by Rho GTPasesTAS
R-HSA-194315Signaling by Rho GTPasesIEA
R-HSA-195258RHO GTPase EffectorsTAS
R-HSA-195258RHO GTPase EffectorsIEA
R-HSA-195721Signaling by WNTTAS
R-HSA-196854Metabolism of vitamins and cofactorsTAS
R-HSA-199991Membrane TraffickingIEA
R-HSA-202131Metabolism of nitric oxideTAS
R-HSA-2025928Calcineurin activates NFATTAS
R-HSA-2025928Calcineurin activates NFATIEA
R-HSA-203615eNOS activationTAS
R-HSA-203765eNOS activation and regulationTAS
R-HSA-2151201Transcriptional activation of mitochondrial biogenesisIEA
R-HSA-2187338Visual phototransductionIEA
R-HSA-2187338Visual phototransductionTAS
R-HSA-2454202Fc epsilon receptor (FCERI) signalingTAS
R-HSA-2454202Fc epsilon receptor (FCERI) signalingIEA
R-HSA-2514856The phototransduction cascadeIEA
R-HSA-2514856The phototransduction cascadeTAS
R-HSA-2514859Inactivation, recovery and regulation of the phototransduction cascadeIEA
R-HSA-2514859Inactivation, recovery and regulation of the phototransduction cascadeTAS
R-HSA-2672351Stimuli-sensing channelsTAS
R-HSA-2871809FCERI mediated Ca+2 mobilizationTAS
R-HSA-2871809FCERI mediated Ca+2 mobilizationIEA
R-HSA-372790Signaling by GPCRTAS
R-HSA-372790Signaling by GPCRIEA
R-HSA-382551Transport of small moleculesTAS
R-HSA-3858494Beta-catenin independent WNT signalingTAS
R-HSA-388396GPCR downstream signallingTAS
R-HSA-388396GPCR downstream signallingIEA
R-HSA-392499Metabolism of proteinsTAS
R-HSA-397014Muscle contractionTAS
R-HSA-397014Muscle contractionIEA
R-HSA-4086398Ca2+ pathwayTAS
R-HSA-418346Platelet homeostasisTAS
R-HSA-418359Reduction of cytosolic Ca++ levelsTAS
R-HSA-418360Platelet calcium homeostasisTAS
R-HSA-418594G alpha (i) signalling eventsTAS
R-HSA-418594G alpha (i) signalling eventsIEA
R-HSA-425393Transport of inorganic cations/anions and amino acids/oligopeptidesTAS
R-HSA-425407SLC-mediated transmembrane transportTAS
R-HSA-425561Sodium/Calcium exchangersTAS
R-HSA-438064Post NMDA receptor activation eventsTAS
R-HSA-438064Post NMDA receptor activation eventsIEA
R-HSA-4420097VEGFA-VEGFR2 PathwayIEA
R-HSA-4420097VEGFA-VEGFR2 PathwayTAS
R-HSA-442717CREB phosphorylation through the activation of CaMKKTAS
R-HSA-442717CREB phosphorylation through the activation of CaMKKIEA
R-HSA-442729CREB phosphorylation through the activation of CaMKIITAS
R-HSA-442742CREB phosphorylation through the activation of RasTAS
R-HSA-442745Activation of CaMK IVTAS
R-HSA-442745Activation of CaMK IVIEA
R-HSA-442755Activation of NMDA receptor and postsynaptic eventsTAS
R-HSA-442755Activation of NMDA receptor and postsynaptic eventsIEA
R-HSA-442982Ras activation upon Ca2+ influx through NMDA receptorTAS
R-HSA-445355Smooth Muscle ContractionIEA
R-HSA-445355Smooth Muscle ContractionTAS
R-HSA-451306Ionotropic activity of kainate receptorsTAS
R-HSA-451308Activation of Ca-permeable Kainate ReceptorTAS
R-HSA-451326Activation of kainate receptors upon glutamate bindingTAS
R-HSA-5210891Uptake and function of anthrax toxinsTAS
R-HSA-5218920VEGFR2 mediated vascular permeabilityTAS
R-HSA-5218921VEGFR2 mediated cell proliferationIEA
R-HSA-5339562Uptake and actions of bacterial toxinsTAS
R-HSA-5576891Cardiac conductionTAS
R-HSA-5576892Phase 0 - rapid depolarisationTAS
R-HSA-5578775Ion homeostasisTAS
R-HSA-5607763CLEC7A (Dectin-1) induces NFAT activationTAS
R-HSA-5607763CLEC7A (Dectin-1) induces NFAT activationIEA
R-HSA-5607764CLEC7A (Dectin-1) signalingTAS
R-HSA-5607764CLEC7A (Dectin-1) signalingIEA
R-HSA-5621481C-type lectin receptors (CLRs)TAS
R-HSA-5621481C-type lectin receptors (CLRs)IEA
R-HSA-5626467RHO GTPases activate IQGAPsTAS
R-HSA-5627123RHO GTPases activate PAKsTAS
R-HSA-5627123RHO GTPases activate PAKsIEA
R-HSA-5653656Vesicle-mediated transportIEA
R-HSA-5663205Infectious diseaseTAS
R-HSA-5673001RAF/MAP kinase cascadeTAS
R-HSA-5683057MAPK family signaling cascadesTAS
R-HSA-5684996MAPK1/MAPK3 signalingTAS
R-HSA-597592Post-translational protein modificationTAS
R-HSA-70221Glycogen breakdown (glycogenolysis)TAS
R-HSA-70221Glycogen breakdown (glycogenolysis)IEA
R-HSA-71387Metabolism of carbohydratesTAS
R-HSA-71387Metabolism of carbohydratesIEA
R-HSA-76002Platelet activation, signaling and aggregationTAS
R-HSA-76005Response to elevated platelet cytosolic Ca2+TAS
R-HSA-8876725Protein methylationTAS
R-HSA-8978934Metabolism of cofactorsTAS
R-HSA-8982491Glycogen metabolismTAS
R-HSA-8982491Glycogen metabolismIEA
R-HSA-9006925Intracellular signaling by second messengersTAS
R-HSA-9006925Intracellular signaling by second messengersIEA
R-HSA-9006934Signaling by Receptor Tyrosine KinasesIEA
R-HSA-9006934Signaling by Receptor Tyrosine KinasesTAS
R-HSA-936837Ion transport by P-type ATPasesTAS
R-HSA-983695Antigen activates B Cell Receptor (BCR) leading to generation of second messengersIEA
R-HSA-983705Signaling by the B Cell Receptor (BCR)TAS
R-HSA-983705Signaling by the B Cell Receptor (BCR)IEA
R-HSA-983712Ion channel transportTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
21546767Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. (2011)Murea MAm J Nephrol